Company Overview of Kinexum Metabolics, Inc.
Kinexum Metabolics, Inc. operates as a biopharmaceutical company focused on the development of therapies for the treatment of type 1 and type 2 diabetes and other metabolic conditions. It offers INGAP Peptide, an islet neogenesis agent that causes insulin secreting cells to be regenerated from precursor cells. The company was incorporated in 2006 and is based in Edina, Minnesota.
7101 York Avenue South
Edina, MN 55436
Founded in 2006
Key Executives for Kinexum Metabolics, Inc.
Similar Private Companies By Industry
|Savage Laboratories, Inc.||United States|
|ContraFect Corporation||United States|
|Chembridge Corporation||United States|
|SIA Pharma LLC||United States|
|Bio Matrix||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Summit, NJ | DiversantPosted: Jul 03
- Fort Lauderdale, FL | Broward HealthPosted: Dec 16
- Brown Deer, WI | Kelly Scientific ResourcesPosted: Dec 13
- Spring House, PA | Johnson & JohnsonPosted: Dec 17
Sponsored Financial Commentaries
To contact Kinexum Metabolics, Inc., please visit www.kinexummetabolics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.